Device Trial Radar · NCT02700984
A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial
Last checked: Nov 20, 2026Latest source record: Jan 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
282
Actual
Start
Mar 30, 2016
Primary completion
Apr 18, 2018
Study completion Apr 18, 2018
Sponsor
- Lead sponsor
- Alcon ResearchNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Transcend Medical, Inc.
- First posted
- Mar 7, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long-term safety of the CyPass Micro-Stent in subjects who completed Study Protocol TMI-09-01, COMPASS Trial.
Conditions
- Primary Open Angle Glaucoma (POAG)
Interventions
CyPass Micro-StentDevice
The CyPass Micro-Stent is a small tube with a through-lumen designed to redirect aqueous fluid from the front into the back of the eye. The device is implanted after completion of cataract surgery.
Cataract SurgeryProcedure
Cataract surgery involves the removal of the natural lens, which has become clouded (called a cataract), and insertion of an artificial lens (called an intraocular lens). This procedure is done through a small surgical incision in the eye.
Primary outcomes
What the sponsor says the trial is designed to measure.
- 5-year Annualized Rate (Percentage) of Sight-threatening Adverse Events, by Treatment GroupTime frame: Up to Month 60 postoperative
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
Alcon Investigative Site
Glendale, Arizona
Alcon Investigative Site
Fayetteville, Arkansas
Alcon Investigative Site
La Jolla, California
19 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.